These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 32023964)
21. On the histogenesis and morphology of ovarian carcinomas. Dallenbach-Hellweg G J Cancer Res Clin Oncol; 1984; 107(2):71-80. PubMed ID: 6715398 [TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic Features and the Loss of ARID1A Expression in Ovarian Seromucinous Borderline Tumors and Seromucinous Carcinomas. Ok Atılgan A; Özen Ö; Haberal Reyhan AN; Ayhan A Int J Surg Pathol; 2023 Jun; 31(4):398-408. PubMed ID: 36452965 [TBL] [Abstract][Full Text] [Related]
23. The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications. Meinhold-Heerlein I; Fotopoulou C; Harter P; Kurzeder C; Mustea A; Wimberger P; Hauptmann S; Sehouli J Arch Gynecol Obstet; 2016 Apr; 293(4):695-700. PubMed ID: 26894303 [TBL] [Abstract][Full Text] [Related]
24. Three cases of seromucinous carcinoma of the ovary arising in endometriotic cysts. Taga Y; Chigusa Y; Minamiguchi S; Kido A; Horikawa N; Horie A; Hamanishi J; Kondoh E; Mandai M; Yamaguchi K Int Cancer Conf J; 2021 Jan; 10(1):46-53. PubMed ID: 33489701 [TBL] [Abstract][Full Text] [Related]
25. PAX2, PAX8 and CDX2 Expression in Metastatic Mucinous, Primary Ovarian Mucinous and Seromucinous Tumors and Review of the Literature. Ates Ozdemir D; Usubutun A Pathol Oncol Res; 2016 Jul; 22(3):593-9. PubMed ID: 26797858 [TBL] [Abstract][Full Text] [Related]
26. MRI of Borderline Epithelial Ovarian Tumors: Pathologic Correlation and Diagnostic Challenges. Tsuboyama T; Sato K; Ota T; Fukui H; Onishi H; Nakamoto A; Tatsumi M; Tomiyama N Radiographics; 2022; 42(7):2095-2111. PubMed ID: 36083804 [TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical characterization of mullerian mucinous borderline tumors: possible histogenetic link with serous borderline tumors and low-grade endometrioid tumors. Yasunaga M; Ohishi Y; Oda Y; Misumi M; Iwasa A; Kurihara S; Nishimura I; Okuma E; Kobayashi H; Wake N; Tsuneyoshi M Hum Pathol; 2009 Jul; 40(7):965-74. PubMed ID: 19269675 [TBL] [Abstract][Full Text] [Related]
28. [Pitfalls and common problems in the differential diagnosis of epithelial ovarian tumors]. Lax SF Pathologe; 2019 Feb; 40(1):46-60. PubMed ID: 30719693 [TBL] [Abstract][Full Text] [Related]
29. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Obata K; Morland SJ; Watson RH; Hitchcock A; Chenevix-Trench G; Thomas EJ; Campbell IG Cancer Res; 1998 May; 58(10):2095-7. PubMed ID: 9605750 [TBL] [Abstract][Full Text] [Related]
31. Pelvic seromucinous borderline tumor 26 years after ovarian seromucinous borderline tumor managed with post-treatment estrogen replacement therapy. Uehara T; Yoshida H; Kato T Gynecol Oncol Rep; 2021 Feb; 35():100692. PubMed ID: 33490352 [TBL] [Abstract][Full Text] [Related]
32. Ovarian Seromucinous Borderline Tumor and Clear Cell Carcinoma: An Unusual Combination. Nakamura E; Sato Y; Moriguchi S; Yamashita A; Higo T; Asada Y Case Rep Obstet Gynecol; 2015; 2015():690891. PubMed ID: 26075120 [TBL] [Abstract][Full Text] [Related]
33. Mucinous ovarian tumors of Mullerian-type: an analysis of 17 cases including borderline tumors and intraepithelial, microinvasive, and invasive carcinomas. Dubé V; Roy M; Plante M; Renaud MC; Têtu B Int J Gynecol Pathol; 2005 Apr; 24(2):138-46. PubMed ID: 15782070 [TBL] [Abstract][Full Text] [Related]
34. Newly Categorized Seromucinous Tumor of the Ovary: Magnetic Resonance Imaging Findings. Han JW; Kim KA; Chang HY; Kim JW; Park YS; Lee J; Choi JW; Lee CH; Park CM J Comput Assist Tomogr; 2019; 43(1):119-127. PubMed ID: 30052618 [TBL] [Abstract][Full Text] [Related]
35. Miscellaneous types of surface epithelial neoplasms. The well-differentiated end of the morphologic spectrum of endometrioid, clear-cell, and Brenner tumors and mixed epithelioid tumors of low malignant potential of müllerian type. Kempson RL; Hendrickson MR Pathology (Phila); 1993; 1(2):335-65. PubMed ID: 9420923 [TBL] [Abstract][Full Text] [Related]
36. Comparison of Benign, Borderline, and Malignant Ovarian Seromucinous Neoplasms on MR Imaging. Saida T; Yoshida M; Ishiguro T; Hoshiai S; Sakai M; Amano T; Shibuki S; Satoh T; Nakajima T Magn Reson Med Sci; 2024 Aug; ():. PubMed ID: 39218642 [TBL] [Abstract][Full Text] [Related]
37. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei. McKenney JK; Soslow RA; Longacre TA Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868 [TBL] [Abstract][Full Text] [Related]
38. Seromucinous and Mucinous Borderline Ovarian Tumors: We Need to Know More. Laban M; Chen X; Guo B Reprod Sci; 2023 May; 30(5):1684-1685. PubMed ID: 36474132 [TBL] [Abstract][Full Text] [Related]
39. Histochemical analysis of estrogen and progesterone receptors and gastric-type mucin in mucinous ovarian tumors with reference to their pathogenesis. Shiohara S; Shiozawa T; Shimizu M; Toki T; Ishii K; Nikaido T; Fujii S Cancer; 1997 Sep; 80(5):908-16. PubMed ID: 9307191 [TBL] [Abstract][Full Text] [Related]
40. Endocervical-like (Müllerian) mucinous borderline tumours of the ovary are frequently associated with the KRAS mutation. Kim KR; Choi J; Hwang JE; Baik YA; Shim JY; Kim YM; Robboy SJ Histopathology; 2010 Oct; 57(4):587-96. PubMed ID: 20955384 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]